R. Neve et al., THE EPITHELIUM-SPECIFIC ETS TRANSCRIPTION FACTOR ESX IS ASSOCIATED WITH MAMMARY-GLAND DEVELOPMENT AND INVOLUTION, The FASEB journal, 12(14), 1998, pp. 1541-1550
To study mammary gland expression of the epithelium-restricted Ets fac
tor, ESX, mouse cDNA and genomic sequences were cloned and a similar t
o 350 bp proximal promoter region with >80% mouse-human homology was i
dentified that mediates ESX induction by serum, heregulin (HRG)I or ep
idermal growth factor (EGF). ESX mRNA expression progressively increas
es during embryonic mouse development from day 7 and is detectable in
virgin mammary glands; it shows little if any change during pregnancy,
then declines to barely detectable levels after 3 days of lactation.
Similarly, cultured HC11 cells from midpregnant mouse mammary epitheli
um show an increase in ESX expression upon reaching lactogenic compete
ncy (in the presence of EGF or HRG), with a decline to barely detectab
le levels upon exposure to lactogenic hormones that induce milk protei
n (beta-casein) expression. In contrast, involuting mouse and rat mamm
ary glands show maximal ESX expression. High ESX levels are also seen
in the involuting ventral prostate gland of rats. These findings, incl
uding the persistence of up-regulated ESX in fully regressed mammary g
lands, suggest that ESX expression can be induced by soluble growth fa
ctors and is maximally up-regulated in those partially com mitted epit
helial cells destined to survive both the apoptotic and remodeling pha
ses of glandular involution.